About Us
Quantics is a biostatistical solutions provider for the bioscience and medical devices industries. Through our expert consultancy and QuBAS, our powerful bioassay software, we deliver rapid, guaranteed reliable results that make the most of every datapoint, helping clients to move rapidly through research and development to market approval.
We specialise in biostatistical services and tools to improve outcomes from lab to licence.
“We love stats, so you don’t have to.”
Meet Our Team Of Experts
Quantics brings together a diverse team of highly qualified and experienced statisticians, scientists, and medical professionals. Our multidisciplinary expertise enables us to understand complex scientific and medical questions, design robust experiments and clinical trials, and apply the most appropriate statistical methodologies. Equally important, it allows us to interpret results within their scientific and clinical context and translate them into clear, actionable insights that help our clients make informed decisions.
Matthew Stephenson
Director of Statistics
–
Matthew has been working Quanitcs with since 2015.
Completing his PhD in Statistics at the University of Guelph in 2019, he was awarded the 2020 Canadian Journal of Statistics Award for research on leveraging the graphical structure among predictors to improve outcome prediction.
Matthew served as an Assistant Professor in Statistics at the University of New Brunswick from 2020-2022, resuming a full-time role at Quantics in 2023.
He is co-author of ‘Biostatistics for Bioassay’.
Sandra Quickert
Associate Director of Statistics
–
She holds both a Masters and PhD in Mathematics from the University of Bonn in Germany.
Since joining Quantics in 2017, Sandra has been a member of our Clinical, Bioassay and HTA teams.
She is the responsible statistician for many of our key client clinical trials for medical devices and pharmaceuticals.
Philip Speakman
Chief Executive Officer
–
With degrees in Marketing and Business, Philip has held senior commercial roles in ICI, AstraZeneca, Avecia, and PharmAthene.
He has worked with Quantics since 2015.
Philp has operated internationally in the areas of vaccines, pharmaceuticals, biosciences, specialty chemicals.
Philip first engaged as a client of Quantics while serving as Programme Director for a US, UK and Canadian Government funded Recombinant Plague Vaccine Programme.
Christophe Ladroue
Director of Software Development & Programming
–
Christophe holds a PhD in Pattern Recognition from the University of London, a Masters in Artificial Intelligence from the Université Pierre et Marie Curie and mathematics degree from Université Paris.
Serving at Quantics since 2015, Christophe leads our programming teams for both consultancy services and our proprietary QuBAS Bioassay Software.
Employee Owned
Quantics is owned by the employees of the company. This means that everyone working at Quantics has a vested interest in ensuring the success of our clients. The company is and will remain independent so our clients can be confident that they will always receive a personalised service.
Quality Assured
Quantics provides an independent QA certificate for all GLP and GMP work to satisfy the regulatory requirements. Clients are welcome to conduct an on-site or remote audit should they wish.
MEMBERSHIP SCHEMES
Good Laboratory Practice (GLP)
International Standards Organization (ISO9001).
Quantics is delighted to confirm that we have once again passed our latest ISO9001 audit. You can view our up-to-date ISO certificate here:
NON-MEMBERSHIP SCHEMES
Good Manufacturing Practice (GMP)
Good Clinical Practice (GCP)
FDA 21 CFR part11
Get in touch to find out more. We are more than happy to answer any questions you may have.